_id

690da8e5ccc777a4e85d080f

Ticker

ACHV

Name

Achieve Life Sciences Inc

Exchange

NASDAQ

Address

22722 29th Dr. SE, Bothell, WA, United States, 98021

Country

USA

Sector

Healthcare

Industry

Biotechnology

Currency

USD

Website

https://www.achievelifesciences.com

Description

Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.

Last Close

4.61

Volume

1130107

Current Price

4.69

Change

1.7353579175705003

Last Updated

2025-11-28T11:47:37.643Z

Image

-

Ipo Date

1995-10-13T00:00:00.000Z

Market Cap

257652512

Next Dividend Date

-

Dividend Frequency

-

Dividend Rate

-

Dividend Yield

0

Sentiment

0.99525

Sentiment Sources

4

Rating

4.875

Target Price

15.8889

Strong Buy

7

Buy

1

Hold

0

Sell

0

Strong Sell

0

Current Quarter

2025-09-30

Revenue

0

Cost Of Revenue

-

Gross Profit

-

Operating Expenses

14692000

Operating Income

-14692000

Interest Expense

192000

Pretax Income

-14441000

Net Income

-14441000

Eps

-0.4163462598549601

Dividends Per Share

-

Shares Outstanding

53233988

Income Tax Expense

-

EBITDA

-14194000

Operating Margin

-

Total Other Income Expense Net

251000

Cash

31930000

Short Term Investments

16184000

Receivables

-

Inventories

-

Total Current Assets

50055000

Property Plant Equipment

79000

Total Assets

52040000

Payables

1943000

Short Term Debt

1263000

Long Term Debt

8674000

Total Liabilities

18425000

Equity

33615000

Depreciation

54000

Change In Working Capital

597000

Cash From Operations

-11331000

Capital Expenditures

0

Cash From Investing

-12654000

Cash From Financing

4042000

Net Change In Cash

-19944000

PE

-

PB

4.839297565967574

ROE

-42.95998810055035

ROA

-27.74980784012298

FCF

-11331000

Fcf Percent

-

Piotroski FScore

1

Health Score

34

Deep Value Investing Score

3

Defensive Investing Score

6.5

Dividend Investing Score

1.5

Economic Moat Investing Score

3.3

Garp Investing Score

1.5

Growth Investing Score

0.5

Momentum Investing Score

3.5

Net Net Investing Score

1

Quality Investing Score

2

Value Investing Score

2.5

Quarters > 0 > quarter

2025-09-30

Quarters > 0 > income Statement > revenue

0

Quarters > 0 > income Statement > cost Of Revenue

-

Quarters > 0 > income Statement > gross Profit

-

Quarters > 0 > income Statement > operating Expenses

14692000

Quarters > 0 > income Statement > operating Income

-14692000

Quarters > 0 > income Statement > interest Expense

192000

Quarters > 0 > income Statement > pretax Income

-14441000

Quarters > 0 > income Statement > net Income

-14441000

Quarters > 0 > income Statement > eps

-0.4163462598549601

Quarters > 0 > income Statement > dividends Per Share

-

Quarters > 0 > income Statement > shares Outstanding

34685072

Quarters > 0 > income Statement > income Tax Expense

-

Quarters > 0 > income Statement > EBITDA

-14194000

Quarters > 0 > income Statement > operating Margin

-

Quarters > 0 > income Statement > total Other Income Expense Net

251000

Quarters > 0 > balance Sheet > cash

31930000

Quarters > 0 > balance Sheet > short Term Investments

16184000

Quarters > 0 > balance Sheet > receivables

-

Quarters > 0 > balance Sheet > inventories

-

Quarters > 0 > balance Sheet > total Current Assets

50055000

Quarters > 0 > balance Sheet > property Plant Equipment

79000

Quarters > 0 > balance Sheet > total Assets

52040000

Quarters > 0 > balance Sheet > payables

1943000

Quarters > 0 > balance Sheet > short Term Debt

1263000

Quarters > 0 > balance Sheet > long Term Debt

8674000

Quarters > 0 > balance Sheet > total Liabilities

18425000

Quarters > 0 > balance Sheet > equity

33615000

Quarters > 0 > cash Flow > net Income

-14441000

Quarters > 0 > cash Flow > depreciation

54000

Quarters > 0 > cash Flow > change In Working Capital

597000

Quarters > 0 > cash Flow > cash From Operations

-11331000

Quarters > 0 > cash Flow > capital Expenditures

0

Quarters > 0 > cash Flow > cash From Investing

-12654000

Quarters > 0 > cash Flow > cash From Financing

4042000

Quarters > 0 > cash Flow > net Change In Cash

-19944000

Quarters > 0 > ratios > PE

-0.4163462598549601

Quarters > 0 > ratios > PB

4.839297565967574

Quarters > 0 > ratios > ROE

-42.95998810055035

Quarters > 0 > ratios > ROA

-27.74980784012298

Quarters > 0 > ratios > FCF

-11331000

Quarters > 0 > ratios > Piotroski FScore

1

Quarters > 0 > ratios > fcf Percent

-

Quarters > 0 > health Score

34

Quarters > 1 > quarter

2025-06-30

Quarters > 1 > income Statement > revenue

0

Quarters > 1 > income Statement > cost Of Revenue

55000

Quarters > 1 > income Statement > gross Profit

-55000

Quarters > 1 > income Statement > operating Expenses

12563000

Quarters > 1 > income Statement > operating Income

-12563000

Quarters > 1 > income Statement > interest Expense

191000

Quarters > 1 > income Statement > pretax Income

-12718000

Quarters > 1 > income Statement > net Income

-12718000

Quarters > 1 > income Statement > eps

-0.3666707106734563

Quarters > 1 > income Statement > dividends Per Share

-

Quarters > 1 > income Statement > shares Outstanding

34685072

Quarters > 1 > income Statement > income Tax Expense

-

Quarters > 1 > income Statement > EBITDA

-12472000

Quarters > 1 > income Statement > operating Margin

-

Quarters > 1 > income Statement > total Other Income Expense Net

-155000

Quarters > 1 > balance Sheet > cash

51874000

Quarters > 1 > balance Sheet > short Term Investments

3523000

Quarters > 1 > balance Sheet > receivables

-

Quarters > 1 > balance Sheet > inventories

-

Quarters > 1 > balance Sheet > total Current Assets

56903000

Quarters > 1 > balance Sheet > property Plant Equipment

93000

Quarters > 1 > balance Sheet > total Assets

58935000

Quarters > 1 > balance Sheet > payables

1218000

Quarters > 1 > balance Sheet > short Term Debt

1266000

Quarters > 1 > balance Sheet > long Term Debt

8657000

Quarters > 1 > balance Sheet > total Liabilities

17267000

Quarters > 1 > balance Sheet > equity

41668000

Quarters > 1 > cash Flow > net Income

-12718000

Quarters > 1 > cash Flow > depreciation

55000

Quarters > 1 > cash Flow > change In Working Capital

595000

Quarters > 1 > cash Flow > cash From Operations

-9069000

Quarters > 1 > cash Flow > capital Expenditures

0

Quarters > 1 > cash Flow > cash From Investing

6703000

Quarters > 1 > cash Flow > cash From Financing

41222000

Quarters > 1 > cash Flow > net Change In Cash

38858000

Quarters > 1 > ratios > PE

-0.3666707106734563

Quarters > 1 > ratios > PB

3.904026775463185

Quarters > 1 > ratios > ROE

-30.522223288854754

Quarters > 1 > ratios > ROA

-21.579706456265377

Quarters > 1 > ratios > FCF

-9069000

Quarters > 1 > ratios > Piotroski FScore

1

Quarters > 1 > ratios > fcf Percent

-

Quarters > 1 > health Score

38

Quarters > 2 > quarter

2025-03-31

Quarters > 2 > income Statement > revenue

0

Quarters > 2 > income Statement > cost Of Revenue

62000

Quarters > 2 > income Statement > gross Profit

-62000

Quarters > 2 > income Statement > operating Expenses

12894000

Quarters > 2 > income Statement > operating Income

-12894000

Quarters > 2 > income Statement > interest Expense

185000

Quarters > 2 > income Statement > pretax Income

-12827000

Quarters > 2 > income Statement > net Income

-12827000

Quarters > 2 > income Statement > eps

-0.3698132729838358

Quarters > 2 > income Statement > dividends Per Share

-

Quarters > 2 > income Statement > shares Outstanding

34685072

Quarters > 2 > income Statement > income Tax Expense

-

Quarters > 2 > income Statement > EBITDA

-12580000

Quarters > 2 > income Statement > operating Margin

-

Quarters > 2 > income Statement > total Other Income Expense Net

67000

Quarters > 2 > balance Sheet > cash

13016000

Quarters > 2 > balance Sheet > short Term Investments

10229000

Quarters > 2 > balance Sheet > receivables

-

Quarters > 2 > balance Sheet > inventories

-

Quarters > 2 > balance Sheet > total Current Assets

25000000

Quarters > 2 > balance Sheet > property Plant Equipment

106000

Quarters > 2 > balance Sheet > total Assets

27358000

Quarters > 2 > balance Sheet > payables

1656000

Quarters > 2 > balance Sheet > short Term Debt

1251000

Quarters > 2 > balance Sheet > long Term Debt

8657000

Quarters > 2 > balance Sheet > total Liabilities

17079000

Quarters > 2 > balance Sheet > equity

10279000

Quarters > 2 > cash Flow > net Income

-12827000

Quarters > 2 > cash Flow > depreciation

62000

Quarters > 2 > cash Flow > change In Working Capital

-660000

Quarters > 2 > cash Flow > cash From Operations

-11088000

Quarters > 2 > cash Flow > capital Expenditures

0

Quarters > 2 > cash Flow > cash From Investing

11353000

Quarters > 2 > cash Flow > cash From Financing

0

Quarters > 2 > cash Flow > net Change In Cash

263000

Quarters > 2 > ratios > PE

-0.3698132729838358

Quarters > 2 > ratios > PB

15.825760062262868

Quarters > 2 > ratios > ROE

-124.78840354120051

Quarters > 2 > ratios > ROA

-46.88573726149573

Quarters > 2 > ratios > FCF

-11088000

Quarters > 2 > ratios > Piotroski FScore

1

Quarters > 2 > ratios > fcf Percent

-

Quarters > 2 > health Score

25

Quarters > 3 > quarter

2024-12-31

Quarters > 3 > income Statement > revenue

228000

Quarters > 3 > income Statement > cost Of Revenue

-

Quarters > 3 > income Statement > gross Profit

114000

Quarters > 3 > income Statement > operating Expenses

12190000

Quarters > 3 > income Statement > operating Income

-12190000

Quarters > 3 > income Statement > interest Expense

197000

Quarters > 3 > income Statement > pretax Income

-12360000

Quarters > 3 > income Statement > net Income

-12360000

Quarters > 3 > income Statement > eps

-0.3581488987240105

Quarters > 3 > income Statement > dividends Per Share

-

Quarters > 3 > income Statement > shares Outstanding

34510786

Quarters > 3 > income Statement > income Tax Expense

-

Quarters > 3 > income Statement > EBITDA

-12105000

Quarters > 3 > income Statement > operating Margin

-5346.491228070176

Quarters > 3 > income Statement > total Other Income Expense Net

-170000

Quarters > 3 > balance Sheet > cash

12733000

Quarters > 3 > balance Sheet > short Term Investments

21607000

Quarters > 3 > balance Sheet > receivables

-

Quarters > 3 > balance Sheet > inventories

-

Quarters > 3 > balance Sheet > total Current Assets

36467000

Quarters > 3 > balance Sheet > property Plant Equipment

119000

Quarters > 3 > balance Sheet > total Assets

38633000

Quarters > 3 > balance Sheet > payables

1950000

Quarters > 3 > balance Sheet > short Term Debt

55000

Quarters > 3 > balance Sheet > long Term Debt

9837000

Quarters > 3 > balance Sheet > total Liabilities

17734000

Quarters > 3 > balance Sheet > equity

20899000

Quarters > 3 > cash Flow > net Income

-12360000

Quarters > 3 > cash Flow > depreciation

58000

Quarters > 3 > cash Flow > change In Working Capital

1406000

Quarters > 3 > cash Flow > cash From Operations

-9189000

Quarters > 3 > cash Flow > capital Expenditures

0

Quarters > 3 > cash Flow > cash From Investing

11717000

Quarters > 3 > cash Flow > cash From Financing

682000

Quarters > 3 > cash Flow > net Change In Cash

3209000

Quarters > 3 > ratios > PE

-0.3581488987240105

Quarters > 3 > ratios > PB

7.744656985501699

Quarters > 3 > ratios > ROE

-59.141585721804866

Quarters > 3 > ratios > ROA

-31.993373540755314

Quarters > 3 > ratios > FCF

-9189000

Quarters > 3 > ratios > Piotroski FScore

1

Quarters > 3 > ratios > fcf Percent

-40.30263157894737

Quarters > 3 > health Score

23

Valuation > metrics > PE

-0.4163462598549601

Valuation > metrics > PB

4.839297565967574

Valuation > final Score

31.60702434032426

Valuation > verdict

61.3% Overvalued

Profitability > metrics > ROE

-42.95998810055035

Profitability > metrics > ROA

-28.8502647088203

Profitability > final Score

15

Profitability > verdict

Weak

Risk > metrics > Debt Equity

0.548118399524022

Risk > metrics > Interest Coverage

-76.52083333333333

Risk > final Score

-258

Risk > verdict

High

Liquidity > metrics > Current Ratio

15.612913287585776

Liquidity > metrics > Quick Ratio

15.612913287585776

Liquidity > final Score

100

Liquidity > verdict

Great

Prev Valuations > 0

40.959732245368144

Prev Valuations > 1

20

Prev Valuations > 2

20

Prev Profitabilities > 0

15

Prev Profitabilities > 1

15

Prev Profitabilities > 2

0

Prev Risks > 0

-203

Prev Risks > 1

-249

Prev Risks > 2

-200

Prev Liquidities > 0

100

Prev Liquidities > 1

100

Prev Liquidities > 2

100

Updated At

2025-12-13T00:23:24.364Z